Surgery Partners (NASDAQ:SGRY) Director Teresa Deluca Purchases 10,000 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) Director Teresa Deluca bought 10,000 shares of the stock in a transaction dated Tuesday, August 18th. The shares were acquired at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Surgery Partners Price Performance

Surgery Partners stock opened at $13.60 on Thursday. The business’s 50 day simple moving average is $15.61 and its 200 day simple moving average is $14.39. Surgery Partners, Inc. has a 12 month low of $11.41 and a 12 month high of $24.10. The company has a market cap of $1.78 billion, a price-to-earnings ratio of -19.43, a PEG ratio of 3.86 and a beta of 1.91. The company has a current ratio of 1.95, a quick ratio of 1.78 and a debt-to-equity ratio of 1.18.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The firm had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. During the same quarter last year, the company earned $0.17 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis. Sell-side analysts forecast that Surgery Partners, Inc. will post 0.25 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. State of Wisconsin Investment Board lifted its position in Surgery Partners by 0.4% during the 4th quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company’s stock valued at $2,341,000 after acquiring an additional 668 shares during the period. ProShare Advisors LLC increased its stake in shares of Surgery Partners by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock valued at $218,000 after purchasing an additional 909 shares in the last quarter. California State Teachers Retirement System increased its stake in shares of Surgery Partners by 1.6% during the second quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock valued at $1,447,000 after purchasing an additional 1,021 shares in the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of Surgery Partners by 4.5% during the fourth quarter. Sanctuary Advisors LLC now owns 28,488 shares of the company’s stock valued at $440,000 after purchasing an additional 1,218 shares during the last quarter. Finally, Empowered Funds LLC lifted its holdings in shares of Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock valued at $305,000 after purchasing an additional 1,278 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on SGRY shares. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Royal Bank Of Canada decreased their price objective on Surgery Partners from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, August 11th. TD Cowen boosted their target price on Surgery Partners from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Raymond James Financial set a $18.00 target price on Surgery Partners in a research note on Tuesday, August 11th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a research report on Tuesday, May 26th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $19.45.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.